Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse

NCT00801216 is registered in ClinicalTrials.gov with Andrés José Maria Ferreri as lead sponsor.

NCT NCT00801216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00801216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse
Lead sponsor
Andrés José Maria Ferreri
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
January 31, 2013
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell lymphomas